APPLICATION OF CONCENTRATES CONTANING VWF FACTOR AS COMBINATION THERAPY AT THE TREATMENT WITH ANTITHROMBOTICS AND FIBRINOLYTICS

摘要

Use of von Willebrand factor (vWF) or fragments with vWF activity is claimed as an antidote to bleeding caused by administration of antithrombotic or fibrinolytic agents. Also claimed is a compsn. contg. (A) an antithrombotic and/or fibrinolytic agent; and (B) vWF or fragments with vWF activity.